Cargando…

Plasma concentration, genetic variation, and gene expression levels of matrix metalloproteinase 9 in Iranian patients with coronary artery disease

BACKGROUND: Matrix metalloproteinase 9 (MMP9) -1562C>T (rs3918242) polymorphism has been proposed as a risk factor for coronary artery disease (CAD) with conflicting results. The aim of the present study was to investigate the association of -1562C>T genetic polymorphism, gene expression and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahmoodi, Khalil, Kamali, Koorosh, Karami, Elham, Soltanpour, Mohammad Soleiman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361445/ https://www.ncbi.nlm.nih.gov/pubmed/28400830 http://dx.doi.org/10.4103/1735-1995.199088

Ejemplares similares

Assessment of the role of plasma nitric oxide levels, T-786C genetic polymorphism, and gene expression levels of endothelial nitric oxide synthase in the development of coronary artery disease
por: Mahmoodi, Khalil, et al.
Publicado: (2017)

Association of Nitric Oxide Levels and Endothelial Nitric Oxide Synthase G894T Polymorphism with Coronary Artery Disease in the Iranian Population
por: Mahmoodi, Khalil, et al.
Publicado: (2016)

Association of the CYP1A1 rs4646903 polymorphism with susceptibility and severity of coronary artery disease
por: Eskandari, Mahsa, et al.
Publicado: (2021)

The association between NFKB1 -94ATTG ins/del and NFKB1A 826C/T genetic variations and coronary artery disease risk
por: Seidi, Abbas, et al.
Publicado: (2018)

A preliminary study of the association between the ABCA1 gene promoter DNA methylation and coronary artery disease risk
por: Ghaznavi, Habib, et al.
Publicado: (2018)

Association Study of the ATP - Binding Cassette Transporter A1 (ABCA1) Rs2230806 Genetic Variation with Lipid Profile and Coronary Artery Disease Risk in an Iranian Population
por: Ghaznavi, Habib, et al.
Publicado: (2018)

Association study between DNA methylation and genetic variation of APOE gene with the risk of coronary artery disease
por: Ghaznavi, Habib, et al.
Publicado: (2018)

Study of alloimmunization and autoimmunization in Iranian β-thalassemia major patients
por: Davari, Kambiz, et al.
Publicado: (2016)

Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy
por: Beránek, Michal, et al.
Publicado: (2008)

Gene Polymorphism of Matrix Metalloproteinase 9 in Asthenozoospermic Male Subjects
por: Mohagheghi, Sina, et al.
Publicado: (2018)

Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma
por: Matulka, Marlena, et al.
Publicado: (2019)

Genomic variations within matrix metalloproteinase-9 and severe sepsis
por: Chen, Q, et al.
Publicado: (2009)

Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2020)

Association of Methylenetetrahydrofolate Reductase C677T Polymorphism with Hyperhomocysteinemia and Deep Vein Thrombosis in the Iranian Population
por: Ghaznavi, Habib, et al.
Publicado: (2015)

Lipoprotein docosapentaenoic acid is associated with serum matrix metalloproteinase-9 concentration
por: Solakivi, Tiina, et al.
Publicado: (2005)

Association study of methylenetetrahydrofolate reductase A1298C mutation with cerebral venous thrombosis risk in an Iranian population
por: Habib, Ghaznavi, et al.
Publicado: (2015)

Prognostic utility of early plasma matrix metalloproteinases -2 and -9 concentrations after severe traumatic brain injury
por: de Lima, Rosane, et al.
Publicado: (2020)

Salivary and plasma levels of matrix metalloproteinase-9 and myeloperoxidase at rest and after acute physical exercise in patients with coronary artery disease
por: Mahmood, Zeid, et al.
Publicado: (2019)

Iranian Oncologists’ Attitude towards Fertility Preservation in a Sample Group
por: Ghorbani, Behzad, et al.
Publicado: (2011)

Association between Expression of Tissue Inhibitors of Metalloproteinases-1, Matrix Metalloproteinase-2, and Matrix Metalloproteinase-9 Genes and Axillary Lymph Nodes Metastasis in Patients with Breast Cancer
por: Abdollahi, Alireza, et al.
Publicado: (2019)

Plasma Levels of Matrix Metalloproteinase-9 in Children With Chronic Spontaneous Urticaria
por: Dilek, Fatih, et al.
Publicado: (2016)

Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis
por: Valente, Flavia Mariana, et al.
Publicado: (2020)

Matrix metalloproteinases in coronary artery disease and myocardial infarction
por: Bräuninger, Hanna, et al.
Publicado: (2023)

Evaluation of Matrix Metalloproteinase 9 Serum Concentration as a Biomarker in Malignant Mesothelioma
por: Štrbac, Danijela, et al.
Publicado: (2019)

Association of MMP2 and MMP9 gene polymorphisms with nonsyndromic cleft lip/palate in an Iranian population
por: Zahedipour, Fatemeh, et al.
Publicado: (2023)

The effect of resveratrol on expression of matrix metalloproteinase 9 and its tissue inhibitors in vascular smooth muscle cells
por: Farrokhi, Effat, et al.
Publicado: (2018)

Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia
por: Kudo, Noriko, et al.
Publicado: (2020)

Association between Serum Vitamin D Concentration Status and Matrix Metalloproteinase-9 in Patients Undergoing Elective Percutaneous Coronary Intervention
por: Foroughinia, Farzaneh, et al.
Publicado: (2020)

Correlation between genetic polymorphism of matrix metalloproteinase-9 in patients with coronary artery disease and cardiac remodeling
por: Yu, Qibin, et al.
Publicado: (2015)

Association of Matrix Metalloproteinases with Coronary Artery Calcification in Patients with CHD
por: Polonskaya, Yana V., et al.
Publicado: (2021)

The influence of matrix metalloproteinase-2, -9, and -12 promoter polymorphisms on Iranian patients with oesophageal squamous cell carcinoma
por: Eftekhary, Haniehsadat, et al.
Publicado: (2015)

Screening PAX9, MSX1 and WNT10A Mutations in 4 Iranian Families with Non-Syndromic Tooth Agenesis
por: Safari, Shiva, et al.
Publicado: (2020)

Interferon-Gamma Increases the Ratio of Matrix Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 in Peripheral Monocytes from Patients with Coronary Artery Disease
por: Springall, Rashidi, et al.
Publicado: (2013)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients
por: Trentini, Alessandro, et al.
Publicado: (2016)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients
por: Hurst, N G, et al.
Publicado: (2007)

Association of the WNT3 Variations and the Risk of Non-Syndromic Cleft Lip and Palate in a Population of Iranian Infants
por: Farrokhi Karibozorg, Homa, et al.
Publicado: (2018)

Important role of matrix metalloproteinase 9 in epileptogenesis
por: Wilczynski, Grzegorz M., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_h7qruj2s9j981m4cmhvg55k8ui